Introduction Global Markets Direct’s, 'Other Bacterial Infections - Pipeline Review, H2 2012', provides an overview of the Other Bacterial Infections therapeutic pipeline. This report provides information on the therapeutic development for Other Bacterial Infections, complete with latest ...

more

GBI Research, the leading business intelligence provider, has released its latest research, “ENT Disorders Market to 2017- Cephalosporins, Quinolones and Macrolides to Replace Older Therapies Due to Anti-Bacterial Resistance”, which provides in-depth analysis of the unmet needs, drivers and ...

more

GBI Research, the leading business intelligence provider, has released its latest research “Hospital Acquired Bacterial Infections Market to 2017 - Niche Players are Most Active in R&D, Positioning Them as Potential Acquisition Targets for Big Pharma”. The report provides in-depth analysis of ...

more

China Pediatric Pharmaceuticals, Inc.(China Pediatric Pharmaceuticals) is a pharmaceutical company principally engaged in the development, manufacture and marketing of over-the-counter (OTC) and prescription pharmaceuticals. The product portfolio of the company includes anti-inflammation, ...

more

Beijing Tiantan Biological Products Co., Ltd. (Tiantan Biological) is a publicly held biotechnology company that is principally engaged in the research, development, manufacture and sale of vaccines for viral and bacterial infections. The product portfolio of the company includes blood ...

more

China Medical System Holdings Limited (CMS) is an integrated pharmaceutical group that focuses on the research development, manufacturing and marketing of pharmaceuticals and medical devices. Its products include Deanxit tablets for the treatment of anxiety, depression, asthenia, and ...

more

Halcygen Pharmaceuticals Limited (Halcygen) is focused on the improvement and reformulation of existing drugs. The company has two products under development which include SUBA-itraconazole and Minocycline. SUBA-itraconazole is a synthetic anti-fungal agent. Minocycline is a member of the ...

more

Basilea Pharmaceutica Ltd. (Basilea) is a publicly held Switzerland-based pharmaceutical company. The company is principally engaged in the discovery, development and commercialization of therapeutics for the treatments of resistant bacterial infections, systemic fungal infections and severe ...

more

NovaBay Pharmaceuticals, Inc. (NovaBay) is a publicly held biopharmaceutical company. It is focused on developing innovative product candidates targeting the treatment of infectious disease. NovaBay has developed its aganocide compounds through research and development based on the human ...

more

Anti-Infective Drugs Markets Six infectious diseases--pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS--account for half of all premature deaths worldwide, killing mostly children and young adults, according to the World Health Organization (WHO). Moreover, ...

more